Fermi Inc. — Investor Relations & Filings
Filings indexed
97
across all filing types
Latest filing
2026-05-22
Proxy Solicitation & In…
Country
US
United States of America
Listing
US
FRMI
Fermi Inc. is a company developing next-generation electric grids and large-scale artificial intelligence (AI) data center campuses. The company's primary project is an advanced energy and AI campus designed to deliver 11 gigawatts of highly redundant power. This infrastructure utilizes a hybrid energy model that integrates nuclear, natural gas, and solar power generation. Fermi's business model involves leasing data center space and providing dedicated, on-site power to clients with significant computational requirements, such as AI laboratories and cloud providers. By co-locating power generation with data centers, the company aims to directly address the substantial energy demands of the AI sector.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| SOLICITING MATERIAL PURSUANT TO 240.14A-12A | 2026-05-22 | English | |
| SOLICITING MATERIAL PURSUANT TO 240.14A-12A | 2026-05-20 | English | |
| SOLICITING MATERIAL PURSUANT TO 240.14A-12A | 2026-05-20 | English | |
| SOLICITING MATERIAL PURSUANT TO 240.14A-12A | 2026-05-19 | English | |
| SOLICITING MATERIAL UNDER 240.14A-12 | 2026-05-19 | English | |
| SOLICITING MATERIAL PURSUANT TO SECTION 240.14A-12 | 2026-05-18 | English |
Browse filings by year
2 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46818097 | SOLICITING MATERIAL PURSUANT TO 240.14A-12A | 2026-05-22 | English | ||
| 46691536 | SOLICITING MATERIAL PURSUANT TO 240.14A-12A | 2026-05-20 | English | ||
| 46601862 | SOLICITING MATERIAL PURSUANT TO 240.14A-12A | 2026-05-20 | English | ||
| 46555844 | SOLICITING MATERIAL PURSUANT TO 240.14A-12A | 2026-05-19 | English | ||
| 46555841 | SOLICITING MATERIAL UNDER 240.14A-12 | 2026-05-19 | English | ||
| 46471531 | SOLICITING MATERIAL PURSUANT TO SECTION 240.14A-12 | 2026-05-18 | English | ||
| 46385489 | Preliminary Consent Revocation Statement | 2026-05-18 | English | ||
| 46359945 | 1st Quarter Results | 2026-05-15 | English | ||
| 46351867 | FRMI Q1 2026 FORM 10-Q | 2026-05-14 | English | ||
| 46302389 | SOLICITING MATERIAL PURSUANT TO 240.14A-12A | 2026-05-14 | English | ||
| 45974874 | 1st Quarter Results | 2026-05-14 | English | ||
| 45865322 | Form 8-K | 2026-05-14 | English | ||
| 45955005 | FRMI FORM 8-K FOR Q1 2026 ER | 2026-05-14 | English | ||
| 45954983 | CURRENT REPORT | 2026-05-14 | English | ||
| 44893805 | First Quarter 2026 Earnings Release & Call Date | 2026-05-11 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
WOOJUNG BIO, Inc.
Offers pre-clinical CRO services, research facility enginee…
|
215380 | KR | Professional, scientific and te… |
|
WuXi AppTec Co., Ltd.
Global CRDMO enabling pharma and life sciences to accelerat…
|
2359 | CN | Professional, scientific and te… |
|
Xceleron Inc.
Specialist provider of ultra-sensitive bioanalytical servic…
|
— | CA | Professional, scientific and te… |
|
XEROS TECHNOLOGY GROUP PLC
Develops and licenses polymer-based solutions that reduce i…
|
XSG | GB | Professional, scientific and te… |
|
Xilio Therapeutics, Inc.
A clinical-stage biotech developing tumor-activated immuno-…
|
XLO | US | Professional, scientific and te… |
|
XINJIANG BAI HUA CUN PHARMA TECH CO.,LTD
Pharmaceutical R&D and CRO services for drug discovery and …
|
600721 | CN | Professional, scientific and te… |
|
Xintela AB
Biomedical company developing stem cell therapies for regen…
|
XINT | SE | Professional, scientific and te… |
|
Xlife Sciences AG
Develops and commercializes early-stage life sciences resea…
|
XLS | CH | Professional, scientific and te… |
|
XtalPi Holdings Limited
Accelerates molecular R&D using AI, quantum physics, and ro…
|
2228 | KY | Professional, scientific and te… |
|
Y-Biologics, Inc
Develops antibody-based therapeutics for cancer, focusing o…
|
338840 | KR | Professional, scientific and te… |
Fermi Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/17756/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=17756 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=17756 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=17756 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 17756}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Fermi Inc. (id: 17756)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.